137 related articles for article (PubMed ID: 1305045)
1. Ukrain both as an anti cancer and immunoregulatory agent.
Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain).
Staniszewski A; Slesak B; Kołodziej J; Harłozińska-Szmyrka A; Nowicky JW
Drugs Exp Clin Res; 1992; 18 Suppl():63-7. PubMed ID: 1305047
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. ("Ukrain") as an immunostimulant in patients with various carcinomas.
Nowicky JW; Staniszewski A; Zbroja-Sontag W; Slesak B; Nowicky W; Hiesmayr W
Drugs Exp Clin Res; 1991; 17(2):139-43. PubMed ID: 1713821
[TBL] [Abstract][Full Text] [Related]
4. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
Cordes N; Plasswilm L; Bamberg M; Rodemann HP
Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
[TBL] [Abstract][Full Text] [Related]
5. Ukrain (NSC-631570) in experimental and clinical studies: a review.
Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM
Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077
[TBL] [Abstract][Full Text] [Related]
6. Results of Ukrain monotherapy of prostate cancer.
Uglyanitsa KN; Nechiporenko NA; Nefyodov LI; Doroshenko YM; Brzosko W; Nowicky W
Drugs Exp Clin Res; 2000; 26(5-6):191-3. PubMed ID: 11345026
[TBL] [Abstract][Full Text] [Related]
7. Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain.
Uglyanitsa KN; Nefyodov LI; Karayedova LM; Nowicky JW; Brzosko W
Drugs Exp Clin Res; 2000; 26(5-6):239-47. PubMed ID: 11345031
[TBL] [Abstract][Full Text] [Related]
8. Ukrain: a novel antitumor drug.
Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
[TBL] [Abstract][Full Text] [Related]
9. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
10. Clinical studies of Ukrain in terminal cancer patients (phase II).
Musianowycz J; Judmajer F; Manfreda D; Spängler P; Albrecht H; Hoffmann J; Meijer D
Drugs Exp Clin Res; 1992; 18 Suppl():45-50. PubMed ID: 1305043
[TBL] [Abstract][Full Text] [Related]
11. Ukrain (NSC-631570) in the treatment of pancreas cancer.
Zemskov VS; Procopchuk OL; Susak YM; Zemskov SV; Hodysh YY; Zemskova MV
Drugs Exp Clin Res; 2000; 26(5-6):179-90. PubMed ID: 11345025
[TBL] [Abstract][Full Text] [Related]
12. Chelidonium majus L. (Ukrain) in the treatment of cancer patients.
Lohninger A; Hamler F
Drugs Exp Clin Res; 1992; 18 Suppl():73-7. PubMed ID: 1305049
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of different doses of Ukrain in the combined treatment of breast cancer.
Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Brzosko WJ
Drugs Exp Clin Res; 2000; 26(5-6):201-21. PubMed ID: 11345028
[TBL] [Abstract][Full Text] [Related]
14. The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky.
Pengsaa P; Wongpratoom W; Vatanasapt V; Udomthavornsuk B; Mairieng E; Tangvorapongchai V; Pesi M; Krusan S; Boonvisoot V; Nowicky JW
Drugs Exp Clin Res; 1992; 18 Suppl():69-72. PubMed ID: 1305048
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies of breast cancer with the antitumor drug Ukrain.
Nefyodov LI; Uglyanitsa KN; Smirnov VY; Karavay AV; Brzosko W
Drugs Exp Clin Res; 2000; 26(5-6):231-7. PubMed ID: 11345030
[TBL] [Abstract][Full Text] [Related]
16. Ukrain treatment of a patient with retroperitoneal synovial sarcoma. Case report.
Prokopchuk OL; Zemskov SV; Susak YM
Drugs Exp Clin Res; 2000; 26(5-6):255-6. PubMed ID: 11345034
[TBL] [Abstract][Full Text] [Related]
17. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. Report 1. Clinical aspects of Ukrain application.
Uglyanitsa KN; Nefyodov LI; Brzosko V
Drugs Exp Clin Res; 2000; 26(5-6):223-30. PubMed ID: 11345029
[TBL] [Abstract][Full Text] [Related]
19. Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report).
Steinacker J; Kroiss T; Korsh OB; Melnyk A
Drugs Exp Clin Res; 1996; 22(3-5):275-7. PubMed ID: 8899347
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of Chelidonium majus L. alkaloid thiophosphoric acid conjugates (Ukrain) on the phenotype of normal human lymphocytes.
Slesak B; Nowicky JW; Harłozinska A
Drugs Exp Clin Res; 1992; 18 Suppl():17-21. PubMed ID: 1305038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
